Similarly, some evidence implies that individuals taking the AMPK agonist metformin or of the dipeptidyl peptidase-IV (DPP4) inhibitor sitagliptin, both drugs widely used to treat hyperglycemia, have a lower risk of PCa [137]. The gene discussed is DPP4; the disease is posterior cortical atrophy.